|
|
| (115 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| | + | |
| | | | |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| − | {{ttp|p=32205092|t=ä. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib |pdf=|usr=}}
| |
| | | | |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| − | {{tp|p=32340833|t=2020. Coronavirus disease 2019 (COVID-19): A literature review |pdf=|usr=}}
| + | *'''[[Clinical guidelines and advice]]''' |
| − | {{tp|p=31967327|t=2020. Emerging coronaviruses: Genome structure, replication, and pathogenesis |pdf=|usr=}}
| + | |
| − | {{tp|p=32238757|t=2020. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32173241|t=ä. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths |pdf=|usr=}}
| + | |
| − | {{tp|p=32035811|t=ä. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| − | *'''[[Clinical guidelines and advice]]''' | + | *'''[[Respiration mgmt]]''' |
| − | {{tp|p=32353109|t=ä. COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and Polypharmacy |pdf=|usr=}}
| + | |
| − | {{tp|p=32343984|t=ä. COVID-19: before stopping specific infection control measures, be sure to exclude the diagnosis |pdf=|usr=}}
| + | |
| − | {{tp|p=32201156|t=ä. Multiple parameters required for diagnosis of COVID-19 in clinical practice |pdf=|usr=}}
| + | |
| − | {{tp|p=32340895|t=ä. Less is More: Intelligent Intensive Care for SARS-CoV-2 Based on the Imaging Data |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[Diagnosis (Laboratory)]]''' |
| | | | |
| | | | |
| | + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| | + | |
| | + | *'''[[Diagnosis (other modalities)]]''' |
| | | | |
| | | | |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Structure of covid19]]''' | | *'''[[Structure of covid19]]''' |
| − | {{tp|p=32361692|t=2020. How the COVID-19 Overcomes the Battle? An Approach to Virus Structure |pdf=|usr=}}
| |
| − | {{tp|p=32306836|t=2020. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment |pdf=|usr=}}
| |
| − | {{tp|p=32145215|t=ä. Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=31994738|t=2020. The 2019?new coronavirus epidemic: Evidence for virus evolution |pdf=|usr=}}
| |
| − | {{tp|p=32027036|t=2020. Genomic variance of the 2019?nCoV coronavirus |pdf=|usr=}}
| |
| − | {{tp|p=32265180|t=ä. Genotype and phenotype of COVID-19: Their roles in pathogenesis |pdf=|usr=}}
| |
| − | {{tp|p=32178970|t=2020. Composition of human-specific slow codons and slow di-codons in SARS-CoV and 2019-nCoV are lower than other coronaviruses suggesting a faster protein synthesis rate of SARS-CoV and 2019-nCoV |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Target binding and uptake]]''' | | *'''[[Target binding and uptake]]''' |
| | + | *'''[[Cytopathic effects]]''' |
| | + | *'''[[Secretion and shedding]]''' |
| | | | |
| | | | |
| − |
| |
| − | *'''[[Cytopathic effects]]'''
| |
| − |
| |
| − | *'''[[Secretion and shedding]]'''
| |
| | | | |
| | *'''[[Innate sensing]]''' | | *'''[[Innate sensing]]''' |
| | | | |
| | *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| − | {{tp|p=31981224|t=2020. Coronavirus infections and immune responses |pdf=|usr=}}
| |
| − | {{tp|p=32198005|t=2020. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| − | {{ttp|p=32205092|t=ä. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | ----
| |
| | | | |
| | + | *'''[[Pathobiology]]''' |
| | | | |
| | | | |
| | + | *'''[[Disease Models]]''' |
| | | | |
| − | *'''[[Early symptoms]]'''
| |
| | | | |
| − | *'''[[Systemic disease, any manifestations]]''' | + | *'''[[Similar diseases and pathomechanisms]]''' |
| | | | |
| − | *'''[[Co-Infection]]'''
| |
| | | | |
| − | *'''[[ARDS]]'''
| |
| | | | |
| − | *'''[[Pulmonary embolism, coagulation]]'''
| |
| − | {{tp|p=32311448|t=ä. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Hematology]]''' | + | *'''[[Early symptoms]]''' |
| | | | |
| − | *'''[[Microvascular]]''' | + | *'''[[Systemic disease, any manifestations]]''' |
| | | | |
| − | *'''[[Heart]]''' | + | *'''[[Co-Infection]]''' |
| − | {{tp|p=32209382|t=ä. The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease |pdf=|usr=}}
| + | |
| − | {{tp|p=32370558|t=2020. Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Neurology, ophthalmology, orl]]''' | + | *'''[[Pulmonary embolism, coagulation]]''' |
| − | *'''[[Dermatology]]'''
| + | |
| | | | |
| − | *'''[[Gastroenterology, hepatology]]'''
| |
| − | {{tp|p=32363540|t=ä. Bowel Necrosis in the Setting of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32298767|t=ä. COVID-19: Abnormal liver function tests |pdf=|usr=}}
| |
| − | {{tp|p=32249184|t=ä. Can COVID-19 present unusual GI symptoms?|pdf=|usr=}}
| |
| | | | |
| − | *'''[[Kidney, urology]]'''
| |
| | | | |
| − | ----
| |
| | | | |
| | | | |
| − | *'''[[Pathobiology]]''' | + | *'''[[Hematology]]''' |
| − | {{tp|p=32283163|t=ä. A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32348495|t=ä. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32344401|t=2020. COVID-19: Possible Impact of the Genetic Background in IFNL Genes on Disease Outcomes |pdf=|usr=}}
| + | |
| − | {{tp|p=32080991|t=2020. Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea |pdf=|usr=}}
| + | |
| − | {{tp|p=32056249|t=2020. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS?CoV, MERS?CoV, and 2019?nCoV |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| − | *'''[[Disease Models]]''' | + | *'''[[Heart]]''' |
| | | | |
| − | *'''[[Similar diseases and pathomechanisms]]'''
| |
| − | ----
| |
| | | | |
| | | | |
| − | *'''[[Diagnosis (Laboratory)]]''' | + | *'''[[Neurology, ophthalmology, orl]]''' |
| − | {{tp|p=32031264|t=2020. Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring |pdf=|usr=}}
| + | |
| − | {{ttp|p=31944312|t=2020. Recent advances in the detection of respiratory virus infection in humans |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Diagnosis (Lung CT, Sonography)]]'''
| |
| − | {{tp|p=32279977|t=ä. What We Know So Far (As of March 26, 2020) About COVID-19 ? An MRT Point of View |pdf=|usr=}}
| |
| − | {{tp|p=32328927|t=2020. (J Med Ultrasound) COVID-19 |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Dermatology]]''' |
| | | | |
| | | | |
| − | *'''[[Diagnosis (other modalities)]]'''
| |
| − | {{tp|p=32344326|t=2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Gastroenterology, hepatology]]''' |
| | | | |
| − | *'''[[Respiration mgmt]]''' | + | *'''[[Kidney, urology]]''' |
| − | {{tp|p=32339975|t=2020. Safe bronchodilator treatment in mechanically ventilated COVID-19 patients: A single center experience |pdf=|usr=}}
| + | |
| − | {{tp|p=32279018|t=ä. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports |pdf=|usr=}}
| + | |
| − | {{tp|p=32317225|t=ä. A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo, Japan: A case report |pdf=|usr=}}
| + | |
| − | {{tp|p=32341785|t=2020. Nationwide system to centralize decisions around ECMO use for severe COVID-19 pneumonia in Japan (Special Correspondence) |pdf=|usr=}}
| + | |
| − | {{tp|p=32288941|t=2020. Japan ECMOnet for COVID-19: telephone consultations for cases with severe respiratory failure caused by COVID-19 |pdf=|usr=}}
| + | |
| | | | |
| | + | *'''[[The morbid survivor]]''' |
| | | | |
| | *'''[[Risk and special populations]]''' | | *'''[[Risk and special populations]]''' |
| − | {{tp|p=32305459|t=2020. Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report |pdf=|usr=}}
| |
| − | {{tp|p=32198004|t=ä. A Patient with SARS-CoV-2 Infection during Pregnancy in Qingdao, China |pdf=|usr=}}
| |
| − | {{tp|p=32147409|t=ä. Are children less susceptible to COVID-19?|pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[The morbid survivor]]''' | + | |
| − | {{tp|p=32334770|t=2020. The Need to Include Assisted Living in Responding to the COVID-19 Pandemic |pdf=|usr=}}
| + | *'''[[Case reports]]''' |
| − | {{tp|p=32222763|t=ä. COVID-19 Through the Lens of Gerontology |pdf=|usr=}}
| + | |
| − | {{tp|p=32305489|t=ä. Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| | | | |
| − | *'''[[Case reports]]'''
| |
| − | {{tp|p=32193905|t=2020. First Pediatric Case of Coronavirus Disease 2019 in Korea |pdf=|usr=}}
| |
| − | {{tp|p=32080990|t=2020. Virus Isolation from the First Patient with SARS-CoV-2 in Korea |pdf=|usr=}}
| |
| − | {{tp|p=32030925|t=2020. The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures |pdf=|usr=}}
| |
| − | {{tp|p=32073161|t=2020. The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019 |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | *'''[[Case series]]''' | | *'''[[Case series]]''' |
| − | {{tp|p=32233161|t=2020. Analysis on 54 Mortality Cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32242348|t=2020. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19 |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Registries]]''' | | *'''[[Registries]]''' |
| − | {{tp|p=32305438|t=ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Trials]]''' | | *'''[[Trials]]''' |
| − | {{tp|p=32290293|t=2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32293807|t=2020. Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID?19: initial assessment |pdf=|usr=}}
| |
| − | {{tp|p=32307268|t=2020. Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC?MSE analysis |pdf=|usr=}}
| |
| − | {{tp|p=32122812|t=2020. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2) |pdf=|usr=}}
| |
| − | {{tp|p=32113846|t=ä. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus |pdf=|usr=}}
| |
| − | {{tp|p=32080993|t=2020. The Author s Response: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR |pdf=|usr=}}
| |
| − | {{tp|p=32080992|t=2020. Letter to the Editor: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR |pdf=|usr=}}
| |
| − | {{tp|p=32056407|t=2020. Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR |pdf=|usr=}}
| |
| − | {{tp|p=32281317|t=2020. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea |pdf=|usr=}}
| |
| − | {{tp|p=32356252|t=ä. COVID-19: Therapeutics and Their Toxicities |pdf=|usr=}}
| |
| − | {{tp|p=32356251|t=ä. Medical Toxicology and COVID-19: Our Role in a Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32052466|t=2020. Potential interventions for novel coronavirus in China: A systematic review |pdf=|usr=}}
| |
| − | {{tp|p=32022276|t=2020. Immunoinformatics?aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019?nCoV |pdf=|usr=}}
| |
| − | {{ttp|p=32249185|t=ä. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection |pdf=|usr=}}
| |
| − | {{ttp|p=32205092|t=ä. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib |pdf=|usr=}}
| |
| − | *[https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds on ivermectin]
| |
| − |
| |
| − |
| |
| − |
| |
| − | ----
| |
| − |
| |
| − | *'''[[Remission, recurrence and persistence]]'''
| |
| − |
| |
| | | | |
| | | | |
| | *'''[[Other routes of infection]]''' | | *'''[[Other routes of infection]]''' |
| − | {{tp|p=32276848|t=ä. Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32224116|t=ä. Do children need a longer time to shed SARS-CoV-2 in stool than adults?|pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Biophysics of aerosols]]''' | | *'''[[Biophysics of aerosols]]''' |
| − | {{tp|p=32340347|t=2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough |pdf=|usr=}}
| |
| − | {{tp|p=32360356|t=ä. Putting some context to the aerosolization debate around SARS-CoV-2 |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Passive protective equipment]]'''
| |
| | | | |
| | | | |
| − | *'''[[Running your hospital]]''' | + | *'''[[Passive protective equipment]]''' |
| − | {{tp|p=32350745|t=ä. Recommendations for the organization of electrophysiology and cardiac pacing services during the COVID-19 pandemic: Latin American Heart Rhythm Society (LAHRS) in collaboration with: Colombian College Of Electrophysiology, Argentinian Society of Cardiac Electrophysiology (SADEC), Brazilian Society Of Cardiac Arrhythmias (SOBRAC), Mexican Society Of Cardiac Electrophysiology (SOMEEC) |pdf=|usr=}}
| + | |
| − | {{tp|p=32269177|t=2020. Resource Allocation and Decision Making for Pediatric and Congenital Cardiac Catheterization During the Novel Coronavirus SARS-CoV-2 (COVID-19) Pandemic: A U S Multi-Institutional Perspective |pdf=|usr=}}
| + | |
| − | {{tp|p=32364347|t=2020. One oral and maxillofacial surgeon s attitude toward the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32193904|t=2020. Drive-Through Screening Center for COVID-19: a Safe and Efficient Screening System against Massive Community Outbreak |pdf=|usr=}}
| + | |
| − | {{tp|p=32301302|t=2020. COVID-19 Screening Center: How to Balance between the Speed and Safety?|pdf=|usr=}}
| + | |
| − | {{tp|p=32301300|t=2020. Walk-Through Screening Center for COVID-19: an Accessible and Efficient Screening System in a Pandemic Situation |pdf=|usr=}}
| + | |
| − | {{tp|p=32301299|t=2020. Fast Screening Systems for COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32301298|t=2020. A Brief Telephone Severity Scoring System and Therapeutic Living Centers Solved Acute Hospital-Bed Shortage during the COVID-19 Outbreak in Daegu, Korea |pdf=|usr=}}
| + | |
| − | {{tp|p=32376717|t=2020. Best interests versus resource allocation: could COVID-19 cloud decision-making for the cognitively impaired?|pdf=|usr=}}
| + | |
| − | {{tp|p=32279976|t=ä. Infection Control in the Medical Imaging Department During the COVID-19 Pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32349962|t=2020. Telemedicine During the COVID-19 Pandemic: Experiences From Western China |pdf=|usr=}}
| + | |
| − | {{tp|p=32350626|t=2020. How about actively using telemedicine during the COVID-19 pandemic?|pdf=|usr=}}
| + | |
| − | {{tp|p=32250962|t=2020. Internet Hospitals Help Prevent and Control the Epidemic of COVID-19 in China: Multicenter User Profiling Study |pdf=|usr=}}
| + | |
| − | {{tp|p=32300906|t=2020. How Can Blockchain Help People in the Event of Pandemics Such as the COVID-19?|pdf=|usr=}}
| + | |
| − | {{tp|p=32284234|t=2020. The preventive strategies of community hospital in the battle of fighting pandemic COVID-19 in Taiwan |pdf=|usr=}}
| + | |
| − | {{tp|p=32220574|t=ä. Featuring COVID-19 cases via screening symptomatic patients with epidemiologic link during flu season in a medical center of central Taiwan |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| − | | + | *'''[[Running your hospital]]''' |
| − | | + | |
| − | ----
| + | |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − | {{tp|p=32259628|t=ä. Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist |pdf=|usr=}}
| |
| − | {{tp|p=32208139|t=ä. Coronavirus Disease 2019 (COVID-19) and Beyond: Micropractices for Burnout Prevention and Emotional Wellness |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| | | | |
| − |
| |
| − | *'''[[Socio-psychiatric aspects of the status hygienicus]]'''
| |
| − | {{tp|p=32307522|t=ä. Assessing the Impact of the COVID-19 Pandemic and Accompanying Mitigation Efforts on Older Adults |pdf=|usr=}}
| |
| − | {{tp|p=32296840|t=ä. Aging in Times of the COVID-19 Pandemic: Avoiding Ageism and Fostering Intergenerational Solidarity |pdf=|usr=}}
| |
| − | {{tp|p=32282920|t=ä. ?We?re staying at home? Association of self-perceptions of aging, personal and family resources and loneliness with psychological distress during the lock-down period of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32355556|t=ä. Impact of coronavirus outbreak on psychological health |pdf=|usr=}}
| |
| − | {{tp|p=32356422|t=2020. Secondary Emotional Reactions to the COVID-19 Outbreak Should Be Identified and Treated in Korea |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| − | {{tp|p=32283124|t=ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| − | {{tp|p=32147406|t=ä. Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China |pdf=|usr=}}
| + | |
| − | {{tp|p=32243947|t=ä. Beyond the assistance: additional exposure situations to COVID-19 for healthcare workers |pdf=|usr=}}
| + | |
| − | {{tp|p=32278703|t=ä. Preventing the Transmission of COVID-19 Amongst Healthcare Workers |pdf=|usr=}}
| + | |
| − | {{tp|p=32278701|t=ä. Knowledge, attitude and practice regarding COVID-19 among health care workers in Henan, China |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − | {{tp|p=32325710|t=2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response |pdf=|usr=}}
| |
| − | {{tp|p=32305533|t=ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review |pdf=|usr=}}
| |
| − | {{tp|p=32292707|t=ä. Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns |pdf=|usr=}}
| |
| − | {{tp|p=32048740|t=2020. Economic impacts of Wuhan 2019?nCoV on China and the world |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| Zeile 271: |
Zeile 145: |
| | | | |
| | *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
| − | {{tp|p=31967321|t=2020. Cross?species transmission of the newly identified coronavirus 2019?nCoV |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
| − | {{tp|p=32277970|t=ä. Strategies to trace back the origin of COVID-19 |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Epidemiology]]''' |
| | | | |
| | | | |
| − | *'''[[Epidemiology]]'''
| |
| − | {{tp|p=32296837|t=ä. Epidemiology of seasonal coronaviruses: Establishing the context for COVID-19 emergence |pdf=|usr=}}
| |
| − | {{tp|p=32365283|t=2020. Lessons learned from HIV can inform our approach to COVID?19 stigma |pdf=|usr=}}
| |
| − | {{tp|p=C7144605|t=ä. Biological and Epidemiological Trends in the Prevalence and Mortality due to Outbreaks of Novel Coronavirus COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32193906|t=2020. Are We Ready for Coronavirus Disease 2019 Arriving at Schools?|pdf=|usr=}}
| |
| − | {{tp|p=32174069|t=2020. Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32030926|t=2020. The Outbreak Cases with the Novel Coronavirus Suggest Upgraded Quarantine and Isolation in Korea |pdf=|usr=}}
| |
| − | {{tp|p=32242349|t=2020. School Opening Delay Effect on Transmission Dynamics of Coronavirus Disease 2019 in Korea: Based on Mathematical Modeling and Simulation Study |pdf=|usr=}}
| |
| − | {{tp|p=32242347|t=2020. Out-of-Hospital Cohort Treatment of Coronavirus Disease 2019 Patients with Mild Symptoms in Korea: an Experience from a Single Community Treatment Center |pdf=|usr=}}
| |
| − | {{tp|p=32242350|t=2020. A Lesson from Temporary Closing of a Single University-affiliated Hospital owing to In-Hospital Transmission of Coronavirus Disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32366705|t=2020. Ethics of instantaneous contact tracing using mobile phone apps in the control of the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32330115|t=2020. Impact of Online Information on Self-Isolation Intention During the COVID-19 Pandemic: Cross-Sectional Study |pdf=|usr=}}
| |
| − | {{tp|p=32287040|t=2020. Cloud-Based System for Effective Surveillance and Control of COVID-19: Useful Experiences From Hubei, China |pdf=|usr=}}
| |
| − | {{tp|p=32353827|t=2020. Containing COVID-19 Among 627,386 Persons in Contact With the Diamond Princess Cruise Ship Passengers Who Disembarked in Taiwan: Big Data Analytics |pdf=|usr=}}
| |
| − | {{tp|p=32189081|t=2020. AI-Driven Tools for Coronavirus Outbreak: Need of Active Learning and Cross-Population Train/Test Models on Multitudinal/Multimodal Data |pdf=|usr=}}
| |
| − | {{tp|p=32056235|t=2020. Does SARS?CoV?2 has a longer incubation period than SARS and MERS?|pdf=|usr=}}
| |
| − | {{tp|p=32027035|t=2020. Transmission dynamics and evolutionary history of 2019?nCoV |pdf=|usr=}}
| |
| − | {{tp|p=32022275|t=2020. The first two cases of 2019?nCoV in Italy: Where they come from?|pdf=|usr=}}
| |
| − | {{tp|p=31997390|t=2020. Potential of large ?first generation? human?to?human transmission of 2019?nCoV |pdf=|usr=}}
| |
| − | {{tp|p=31994742|t=2020. Updated understanding of the outbreak of 2019 novel coronavirus (2019?nCoV) in Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32299783|t=2020. The association between international and domestic air traffic and the coronavirus (COVID-19) outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32205091|t=ä. Internationally lost COVID-19 cases |pdf=|usr=}}
| |
| − | {{tp|p=32224117|t=2020. Evolving reporting criteria of COVID-19 in Taiwan during the epidemic |pdf=|usr=}}
| |
| − | {{tp|p=32205090|t=ä. Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | + | *'''[[Remission, recurrence and persistence]]''' |
| | | | |
| | | | |
| − | *'''[[Failure of politics and public health guidance]]'''
| |
| − | {{tp|p=32373315|t=ä. The need to improve the laws and regulations relevant to the outbreak of COVID-19: What might be learned from China?|pdf=|usr=}}
| |
| − | {{tp|p=32302966|t=2020. Health Communication Through News Media During the Early Stage of the COVID-19 Outbreak in China: Digital Topic Modeling Approach |pdf=|usr=}}
| |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| | ---- | | ---- |
| | + | *'''[[Failure of politics and public health guidance]]''' |
| | | | |
| | | | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| − | {{tp|p=32316647|t=2020. Using Social Media to Mine and Analyze Public Opinion Related to COVID-19 in China |pdf=|usr=}}
| + | |
| − | *[https://www.businessinsider.com/nearly-half-of-reopen-america-twitter-accounts-are-bots-report-2020-5?utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter twitter botwar]
| + | |
| − | *[https://www.frontpagemag.com/point/2020/05/obama-clinton-9th-circuit-judges-suspend-bill-daniel-greenfield/ judges declare the Bill of Rights is suspended until the Coronavirus is cured]
| + | |
| − | *[http://freerepublic.com/focus/f-news/3848303/posts They want you divided, and focused on other enemies.]
| + | |
| − | {{tp|p=32352383|t=2020. COVID-19 and the 5G Conspiracy Theory: Social Network Analysis of Twitter Data |pdf=|usr=}}
| + | |
| − | {{tp|p=32343669|t=2020. Creating COVID-19 Stigma by Referencing the Novel Coronavirus as the ?Chinese virus? on Twitter: Quantitative Analysis of Social Media Data |pdf=|usr=}}
| + | |
| − | {{tp|p=32250961|t=2020. COVID-19 Related Misinformation on Social Media: A Qualitative Study from Iran |pdf=|usr=}}
| + | |
| − | {{tp|p=32287039|t=2020. Top Concerns of Tweeters During the COVID-19 Pandemic: Infoveillance Study |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
| − | {{tp|p=32142979|t=2020. Li Wenliang, a face to the frontline healthcare worker The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32271208|t=ä. Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People?s Republic of China |pdf=|usr=}}
| |
| − | {{tp|p=32277966|t=ä. Characteristics of deaths amongst health workers in China during the outbreak of COVID-19 infection |pdf=|usr=}}
| |
| | | | |
| | *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| | + | |
| | ---- | | ---- |
| | | | |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | {{tp|p=32120913|t=2020. Epidemiological Identification of A Novel Pathogen in Real Time: Analysis of the Atypical Pneumonia Outbreak in Wuhan, China, 2019?2020 |pdf=|usr=}}
| + | *'''[[misc.]]''' |
| − | {{tp|p=32001309|t=2020. Emergence of a novel coronavirus causing respiratory illness from Wuhan, China |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[misc.]]''' | + | *'''[[Research tools]]''' |
| − | {{tp|p=32277235|t=ä. My Future in Medicine: How COVID-19 Is Inspiring the Next Generation of Infectious Disease Specialists |pdf=|usr=}}
| + | |
| − | {{tp|p=32229647|t=2020. COVID-19: An Unintended Force for Medical Revolution?|pdf=|usr=}}
| + | |
| − | {{tp|p=32332154|t=2020. Balancing the duty to treat with the duty to family in the context of the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32293580|t=2020. Global Reach of an Online COVID-19 Course in Multiple Languages on OpenWHO in the First Quarter of 2020: Analysis of Platform Use Data |pdf=|usr=}}
| + | |
| − | {{tp|p=32017153|t=2020. Updates on Wuhan 2019 novel coronavirus epidemic |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| − | *'''[[Research tools]]''' | + | |
| | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | + | |
| | + | *'''[[PrePrint scene]]''' |
| | + | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| − | *[lifechemicals.com antiviral candidate drugs]
| |
| − | *[biomol.com assays cytokines general spectrum]
| |
| − | *[labospace.com custom single probe assay 400 possible cytokines and so on]
| |
| − | *[codexdna.com dna synthesis]
| |
| − | *
| |
| | | | |
| | *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| | + | *'''[[on-topic personal thoughts]]''' |
